Related Experiment Video
Updated: May 20, 2026
08:58
En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
Nitric oxide in neurodegenerative diseases
1Center of Brain and Cognitive Sciences, Institute of Biophysics, Academia Sinica, Beijing 100101, PR China. zhaobl@sun5.ibp.ac.cn
Frontiers in Bioscience : a Journal and Virtual Library
|December 3, 2004
Summary
Nitric oxide (NO), a key signaling molecule, is linked to neurodegenerative diseases like Alzheimer's and Parkinson's. This review examines NO's role and antioxidant effects in these conditions.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Nitric oxide (NO) is a critical signaling molecule in the nervous system.
- Neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and stroke, are significant health concerns.
- The precise relationship between NO and these neurological disorders is an active area of research.
Purpose of the Study:
- To review recent findings on the association between nitric oxide and neurodegenerative diseases.
- To specifically examine the role of antioxidants in modulating NO's effects in neurodegenerative disorders.
- To present original research data from the authors' laboratory concerning NO and neurodegeneration.
Main Methods:
- Literature review of recent studies on NO and neurodegenerative diseases.
- Analysis of experimental data on antioxidants and NO in neurodegenerative models.
- Synthesis of findings from the authors' own laboratory research.
Main Results:
- Evidence suggests a complex role for NO in neurodegenerative diseases, potentially acting as both a neuroprotectant and a neurotoxin depending on the context.
- Antioxidants may mitigate NO-related neurotoxicity in conditions like AD, PD, and stroke.
- Author's laboratory data provide specific insights into these interactions.
Conclusions:
- Nitric oxide plays a multifaceted role in the pathogenesis and progression of neurodegenerative diseases.
- Targeting NO pathways and utilizing antioxidants represent potential therapeutic strategies for neuroprotection.
- Further research is warranted to fully elucidate NO's complex involvement and optimize therapeutic interventions.
More Related Videos
08:32Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells
Published on: March 16, 2017
08:23Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...